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Objective: Severe progressive neurological pediatric disease mucopolysaccharidosis III type 
C is caused by mutations in the HGSNAT gene leading to deficiency of acetyl-CoA: α-glucosaminide 
N-acetyltransferase involved in the lysosomal catabolism of heparan sulfate. To understand the 
pathophysiology of the disease we generated a mouse model of mucopolysaccharidosis III type C by 
germline inactivation of the Hgsnat gene.  
Results: At 6-8 months mice showed hyperactivity, and reduced anxiety. Cognitive memory 
decline was detected at 10 months and at 12-13 months mice showed signs of unbalanced hesitant 
walk and urinary retention. Lysosomal accumulation of heparan sulfate was observed in hepatocytes, 
splenic sinus endothelium, cerebral microglia, liver Kupffer cells, fibroblasts and pericytes. Starting 
from 5 months brain neurones showed enlarged, structurally abnormal mitochondria, impaired 
mitochondrial energy metabolism, and storage of densely packed autofluorescent material, 
gangliosides, lysozyme, pTau, and beta amyloid.  
Interpretation: Altogether, our data for the first time demonstrate that deficiency of acetyl-
CoA: α-glucosaminide N-acetyltransferase causes lysosomal accumulation of heparan sulfate in 
microglial cells followed by their activation and cytokine release. They also show mitochondrial 
dysfunction in the neurones and neuronal loss explaining why mucopolysaccharidosis III type C 
manifests primarily as a neurodegenerative disease.  
 
Keywords: glycosaminoglycans; mucopolysaccharidosis; heparan sulfate; acetyl-CoA: α-
glucosaminide N-acetyltransferase; knockout mouse model. 
Abbreviations: MPS = mucopolysaccharidosis; Hgsnat = acetyl-CoA: α-glucosaminide N-
acetyltransferase; HS= heparan sulfate.
  
Introduction 
Mucopolysaccharidosis III or Sanfilippo syndrome is a metabolic genetic disease caused by 
lysosomal accumulation of heparan sulfate (HS) (Neufeld and Muenzer, 2001; Valstar et al., 2008). 
The disease includes four allelic subtypes caused by the genetic deficiencies of heparan N-sulfatase 
(MPS III type A; MIM #252900), α-N-acetylglucosaminidase (MPS III type B; MIM #252920), 
heparan sulfate acetyl-CoA: α-glucosaminide N-acetyltransferase or HGSNAT (MPS III type C; MIM 
#252930), and N-acetylglucosamine 6-sulfatase (MPS III type D; MIM #252940).   
The majority of MPS IIIC patients have severe clinical manifestations with onset in early 
childhood.  They rapidly develop progressive and severe neurological deterioration causing 
hyperactivity, sleep disorders, loss of speech, behavioral abnormalities, neuropsychiatric problems, 
mental retardation, hearing loss, visceral manifestations, such as mild hepatomegaly, mild dysostosis 
multiplex, mild coarse facies, and hypertrichosis (Bartsocas et al., 1979).  Most patients die before 
adulthood but some survive to the fourth decade with progressive dementia and retinitis pigmentosa 
(Neufeld and Muenzer, 2001; Ruijter et al., 2008; Valstar et al., 2008).  The birth prevalence of MPS 
IIIC in Portugal and the Netherlands is 0.12 and 0.21 per 100,000, respectively (Pinto et al., 2004; 
Poorthuis et al., 1999). 
HGSNAT transfers an acetyl group from cytoplasmic acetyl-CoA to terminal N-glucosamine 
residues of HS within the lysosomes(Klein et al., 1978). To date, more than 80 HGSNAT mutations 
have been identified including 18 missense which all result in misfolding of the mutant 
enzyme(Feldhammer et al., 2009) 
Important insights into the physiological mechanism of MPS III have been obtained from 
studying animal models of the disease.  Spontaneous avian(Aronovich et al., 2001) and 
canine(Aronovich et al., 2000; Ellinwood et al., 2003) models of MPS IIIA and B and a caprine model 
of MPS IIID(Ginsberg et al., 1999) have been described, but the majority of data has been obtained 
  
by studying a knockout mouse model of MPS IIIB(Li et al., 1999) and a spontaneous mouse model of 
MPS IIIA(Bhaumik et al., 1999). Several mechanisms potentially underlying neurodegenerative 
process in MPS III were described.  First, in both mouse models microglia cells are activated through 
interaction of their Toll-like receptor 4 (TLR4) with under-degraded HS fragments, as are astrocytes 
and the entire immune system in the brain(Ausseil et al., 2008; DiRosario et al., 2009; Ohmi et al., 
2003; Villani et al., 2007). At the same time, inhibition of TLR4 signaling pathway in MPS IIIB mouse 
while delaying brain inflammation did not stop progression of the neurodegenerative process(Ausseil 
et al., 2008).  Second, storage of GM2 and GM3 gangliosides occurring in brain cerebral cortical and 
cerebellar neurons(McGlynn et al., 2004) (Crawley et al., 2006) was previously suggested to cause 
neuronal apoptosis in Tay-Sachs and Sandhoff diseases where GM2 ganglioside is accumulated due to 
genetic defects of hexosaminidases A and B, respectively (Huang et al., 1997; Wada et al., 2000).  
Interestingly, recently described double-mutant MPS IIIA and IIIB mice with a knockout GalNAc 
transferase crucial for the synthesis of gangliosides have significantly reduced lifespan and increased 
neurodegeneration as compared to the corresponding single-mutant MPS IIIA and MPS IIIB mice, 
suggesting that absence of gangliosides may also be deleterious in MPS III (Mohammed et al., 2012). 
Third, neurodegeneration could be caused by protein aggregates(Ginsberg et al., 1999; Hamano et al., 
2008; Ohmi et al., 2009) detected in neurons of medial entorhinal cortex and the dentate gyrus and 
linked to impaired autophagy and/or increased extralysosomal level of HS proteoglycans, 
glypicans(Ohmi et al., 2011).  Fourth, stored HS fragments, which are in excess and abnormally 
sulfated in MPS IIIA and IIIB(Wilkinson et al., 2012) can cause adverse signaling reactions in brain 
neurons inducing, in particular, overexpression of GM130 protein and subsequent alterations of the 
Golgi ribbon architecture(Roy et al., 2012), enhanced proliferation and outgrowth of 
neurites(Hocquemiller et al., 2010) as well as alteration of neural cell migration (Bruyere 2013, 
submitted) all potentially contributing to neuropathology.   
  
 However, it still remains to be determined which of the above mechanisms are important for 
the development of neuronal dysfunction and, therefore should be the target for the pharmaceutical 
intervention along with finding the ways to restore deficient HGSNAT activity in the patients’ cells. 
It is also not understood whether the pathophysiological mechanism in all 4 subtypes of MPS III is the 
same despite different genetic and biochemical defects and severity of the clinical manifestation.  
In the current work we report the generation of the first animal model of the MPS IIIC by 
inactivation of the Hgsnat gene in mice and present new pathological and mechanistic findings 
explaining the brain disease progression by the neuronal loss associated with mitochondrial 
dysfunction.  
  
Subjects/Materials and Methods 
Animals. Generation of C57Bl6 mice with targeted disruption of Hgsnat gene has been 
performed at Texas Institute for Genomic Medicine as previously described(Hansen et al., 2008; 
Zambrowicz et al., 2003). The heterozygous mice were crossed to C57BL/6NCrl strain distributed by 
Charles River Quebec or bred to each other and the litter genotyped by PCR as described below. The 
Hgsnat-Geo mice were compared with the appropriate age and sex-matching wild type controls. All 
mice were bred and maintained at the Canadian Council on Animal Care (CCAC)-accredited animal 
facilities of the CHU Ste-Justine Research Center according to the CCAC guidelines.  Mice were 
housed in an enriched environment with continuous access to food and water, under constant 
temperature and humidity, on a 12 h light/dark cycle. Approval for the animal experimentation was 
granted by the Animal Care and Use Committee of the CHU Ste-Justine.  
The genotypes of mice were determined using genomic DNA extracted from the clipped tail 
tip (see Extended Materials and Methods for sequences of primers and PCR conditions). A 463 and 
297 bp fragments were amplified separately in wild type and Hgsnat-Geo homozygous mice, 
respectively, whereas both fragments were amplified in mice heterozygous for the Hgsnat-Geo allele.  
Quantification of mouse Hgsnat mRNA and cytokines in mouse brain tissues was performed 
using a Stratagene Mx3000P QPCR System (see Extended Materials and Methods for sequences of 
primers and PCR conditions). Total RNA was isolated from cultured cells or mouse tissues using the 
Trizol Reagent (Invitrogen) according to the manufacturer’s protocol and reverse-transcribed to cDNA 
using random primers and SuperScript III reverse transcriptase (Invitrogen). RLP32 mRNA was used 
as a reference control.  
Neurological and behavioural examination of mice.  The motor performance of mice 
was evaluated using a simplified neurological examination as previously described(Lema et al., 2004). 
The rotating rod motor coordination test was performed using an accelerating 5-line Rotarod treadmill 
  
for mice (3 cm in diameter).  Animals (8 per age per genotype) were briefly trained at 4 rpm and tested 
using an accelerating mode (from 4 to 40 rpm over 5 min). Three trials separated by 20 min rest 
intervals were performed on 3 consecutive days. The open field test was performed by individually 
placing 2, 4, 6, 8, 10-month-old Hgsnat-Geo, or wild type mice into the center of an arena (40 cm 
length x 40 cm width x 50 cm height, white Plexiglas). Mouse behavior was recorded for one hour 
and analyzed using Top Scan software version 2.0 (Clever Sys. Inc., Reston, VA, USA). The path 
length, rapid exploratory behavior (speed > 100 mm/s), immobility (speed < 0.05 mm/s) as well as 
frequency, path length, duration and speed in the central (25%) area of the cage were analyzed. OFT 
was performed one hour into the mouse light cycle (Langford-Smith et al., 2011a; Langford-Smith et 
al., 2011b). A 30 min room adjustment period was implemented prior to the start of each test. All 
experiments were performed with a naïve group of 6 to10 animals by the same investigator (LG). 
The 5, 7, 8 and 10-month-old mice (six per age per genotype) were subjected to the Morris 
Water Maze test for spatial learning essentially as described (Seyrantepe et al., 2010). During a 3-day 
habituation period, mice were required to swim to a visible platform located in a selected quadrant of 
a circular (1.4 m in diameter and 34 cm high) tank filled with water (18±1°C). The escape latencies 
were measured and visual and motor acuity as well as motivation were tested. On the 4th day, the water 
was made opaque with an inert paint, the platform was moved to a different quadrant and submerged 
(1 cm), the visual wall cues were switched and 5 days of hidden-platform testing ensued. Mice were 
given three trials of 90 s to find the platform (the maximum inter-trial interval was 45 min). On days 
1 and 4, mice that could not find the platform in the allotted time were guided to and allowed to stay 
on it for 10 s. On day 9, following hidden-platform testing, all mice were given a 60 s probe trial in 
which the percentages of time spent and distance traveled in the target quadrant (no longer containing 
a platform), as well as the number of crossings over the previous location of the hidden platform were 
recorded, along with swimming speed. Escape latencies were acquired with the 2020 Plus tracking 
  
system and Water 2020 software (Ganz FC62D video camera; HVS Image, UK). All experiments were 
started at the same time every day and performed by the same investigator (CM). 
 Analysis of glycosaminoglycans and gangliosides in mouse tissues. Total GAG and 
lipids were extracted from brain and liver tissues as previously described (Ausseil et al., 2008). Briefly, 
frozen tissues were homogenized in water (10% v/w). Lipids were extracted by addition of 2 volumes 
of methanol and 1 volume of chloroform to one volume of the homogenate. After 10 min 
centrifugation at 1000 g the organic phase was collected, evaporated and used to analyse gangliosides. 
The pellet was re-suspended in 100 mM sodium acetate buffer pH 5.5, containing 5 mM cysteine, 5 
mM EDTA and 1 mg/ml of papain, digested overnight at 65°C and cleared by centrifugation at 2500 
g for 15 min. For the analysis of total GAG, 100 µl of the supernatant was added to 2.5 ml of 
dimethylmethylene blue reagent (Whitley et al., 1989) and the absorbance at 535 nm was measured. 
GAG concentration (µg per mg of dried pellet) was calculated using purified HS standard. 
 Sphingolipids were extracted from the lipid fraction in the presence of deuterium-labeled 
standards (N-stearoyl (D3)-monosialoganglioside GM2 and N-stearoyl (D
3)-monosialoganglioside 
GM3, Matreya LLC, USA) by saponification(Kyrklund, 1987) and then fractionated and desalted using 
reverse-phase Bond Elut C18 columns. Samples were analyzed by direct flow injection at a rate of 
200 μl/min on a triple-quadrupole mass spectrometer (API 3200 MS/MS; Sciex Applied Biosystems, 
Toronto, Canada) in the negative ionization mode using the multiple reactions monitoring (MRM) 
method. GM2 and GM3 species were measured separately. The concentrations of individual molecular 
species were calculated by comparing with the corresponding internal standards. Total GM2 and GM3 
concentrations (pmol per mg of dried pellet) were calculated as sums of the concentrations of all 
molecular species.  
Lysosomal enzyme assays. N-acetyltransferase, β-galactosidase, α-galactosidase and β-
hexosaminidase activities in cellular and tissue homogenates were assayed using the corresponding 
  
fluorogenic 4-methylumbelliferyl glycoside substrates as previously described(Seyrantepe et al., 
2008). Protein concentration was measured using a Bio-Rad Bradford kit. 
Analysis of LC3 in the mouse brain tissues by Western blot. Total brains were 
homogenized in five volumes of 250 mM sucrose buffer containing 50 mM Tris-HCl pH 7.4, 1 mM 
EDTA and protease inhibitor cocktail using a Dounce homogenizer. Nuclei were cleared by 
centrifugation at 500 g for 10 min at 4°C. Supernatants were mixed with an equal volume of sucrose 
buffer containing 1% Triton X-100 and incubated for one hour at 4°C. Resulting lysates were 
centrifuged for 15 min at 13,000 g and supernatants separated by SDS-PAGE on 15% gels. Western 
blot analyses were performed according to standard protocols using anti-LC3 (Sigma, 1:2,000) and 
12G10 anti-α-tubulin antibody (DSHB, 1:15,000). Equal protein loading was assured by Ponceau S 
staining. Signals were quantified using ImageQuant software.  
Tissue processing for morphological studies. Animals were deeply anesthetized with 
sodium pentobarbital and perfused via intracardiac catheter with phosphate-buffered saline, pH 7.4 
(PBS) followed by 4% paraformaldehyde in PBS. Brains and visceral organs were removed and 
immersed in 4% paraformaldehyde in PBS overnight. Tissues for light microscopy were trimmed, 
dehydrated with an ethanol series followed by acetone, acetone-xylene mixture and xylene and then 
embedded in paraffin. Tissues for fluorescent confocal microscopy were treated sequentially in 10%, 
20% and 30% sucrose in PBS overnight at 4o C and embedded in OCT compound before freezing at -
80o C. Tissues for electron microscopy were trimmed into small cubes, post-fixed with 1% osmium 
tetraoxide, dehydrated with an ethanol series and propylene oxide and embedded in Durcupan-Epon 
mixture.     
Histopathology and immunohistochemistry. Four µm-thick sections of paraffin-
embedded tissues were rehydrated with isopropyl alcohol, and then with 96%, 70%, and 60% ethanol. 
The sections were stained with either hematoxylin and eosin (H&E), or periodic acid-Shiff technique 
  
(PAS), and a set of primary antibodies. In the latter case the sections were treated with 1% NaN3 and 
0.3% H2O2 for 10 min to inactivate endogenous peroxidase, blocked with 5% bovine fetal serum in 
PBS for 30 min (both at room temperature), and incubated with primary antibodies diluted in 5% 
bovine serum albumin in PBS overnight at 4°C. After staining with primary and secondary antibodies 
(see Extended Materials and Methods for the list of antibodies and their dilutions) sections were 
analyzed and photographed using a Nikon E800 equipped with Olympus digital camera (DP70).  
Autofluorescence of neurons was analyzed in unstained sections using fluorescence filter BV-2A (Ex 
400-440 nm/DM 455/BA 470). 
For fluorescent confocal microscopy 40 μm-thick sagittal sections were cut from OCT-
embedded frozen brains using CM3050 S Microtome (Leica). The sections were treated with 1% 
Triton X-100, blocked with 10% goat serum in PBS and incubated overnight at 4oC with primary 
antibodies in 3% goat serum, 0.1% Triton X-100 in PBS followed by secondary antibodies (see 
Extended Materials and Methods for the list of antibodies and their dilutions). The slides were mounted 
with Vectashield mounting medium and analyzed using a LSM510 Meta Laser inverted confocal 
microscope (Zeiss, 63x oil objective, N.A. 1.4).  Images were processed and quantified using the LSM 
image browser software (Zeiss) and Photoshop (Adobe). 
Electron microscopy. Semi-thin sections were cut and stained with toluidin blue and viewed 
by light microscopy. The regions of interest for electron microscopy were selected and ultrathin 
sections were cut and mounted on 200 mesh copper grids. Sections were double contrasted with uranyl 
acetate and lead nitrate and then analyzed using a transmission electron microscope (JEOL 1200 EX).  
Analyses of mitochondrial energy metabolism in mouse brain.  Frozen brain tissues 
were homogenized at 4oC in 20 volumes of 50 mM Tris-HCl buffer pH 7.4, containing 150 mM KCl, 
2 mM EDTA and 0.2 μg/ml of aprotinin. Mitochondria were isolated from the homogenate by 
differential centrifugation as described(Makinen and Lee, 1968). The activities of the mitochondrial 
  
enzymes, NADH: ubiquinone oxidoreductase  (NQR, complex I), succinate:CoQ reductase (SQR, 
complex II), ubiquinol:cytochrome c oxidoreductase (QCCR, complex III), cytochrome c oxidase 
(COX, complex IV), NADH:cytochrome c reductase (NCCR, complex I+III), succinate:cytochrome 
c reductase (SCCR, complex II+III) and citrate synthase (CS) were measured as described(Rustin et 
al., 1994; Srere, 1969). Pyruvate dehydrogenase activity was determined as described (Dudkova et al., 
1995). Protein concentration was measured according to Lowry (Lowry et al., 1951).  
Total content of coenzyme Q10 in brain homogenate was determined as described(Mosca et 
al., 2002) with minor modifications. 100 µl of brain homogenate was diluted with 100 µl of MilliQ 
H2O. Mixture was supplemented with 50 µl of a 1,4-benzoquinone solution (2 mg/ml) and vortexed 
for 10 s. After 10 min 1 ml of n-propanol was added. The mixture was vortexed for 10 s and centrifuged 
at 10,000 rpm for 2 min. 50 µl of the supernatant was analyzed by HPLC using the Supelcosil LC 18 
column (Supelco) eluted by ethanol/methanol (70/30 v/v) mixture at a flow rate of 1 ml/min. UV 
detection was performed at 275 nm. Results were expressed as pmol of Q10 per mg of total protein. 
Quantitative analysis of neuronal density in the mouse brain cortex.  
Four mice (2 male, 2 female) were studied for each age and genotype. For each brain, 3 sagittal 
sections, cut at 1.44, 1.68 and 1.92 mm lateral from bregma, (Paxinos and Franklin, 2013) were 
simultaneously stained with anti-NeuN antibodies as described above. For each section, 2 images of 
the S1 somatosensory cortex (S1Tr and S1HL for 1.44 and S1Tr and S1FL for 1.68 and 1.92 sections) 
were acquired using Nikon Eclipse E600 Epifluorescence Microscope (magnification 200x), Zeiss 
Axiocam 506 digital camera with the same settings for all sections. The acquired images were analyzed 
using Adobe Photoshop CS5 (Adobe Systems Inc., Mountain View, CA, USA). In each image, 2 
rectangular fields with the area of 1.92 mm2 were defined, on the right and left extremities of the 
photographed areas. The numbers of NeuN-stained neuronal nuclei for each field (12 fields for each 
  
mouse) were counted by two non-biased observers blinded for the genotype, age and sex of the 
animals.  
Results 
1. Mice homozygous for Hgsnat-Geo allele show deficient Hgsnat mRNA and 
activity in tissues.  
A functional knockout of the Hgsnat locus in C57Bl/6N mice was generated using gene trap 
technology as previously described (Hansen et al., 2008; Zambrowicz et al., 2003). A selectable 
marker β-geo, a functional fusion between the β-galactosidase-encoding gene and the neo gene from 
Tn5 encoding an aminoglycoside 3'-phosphotransferase, was inserted into the intron 7 of the Hgsnat 
gene leading to splicing of exon 7 into the β-geo cassette to generate a fusion protein containing Hgsnat 
amino acid sequence encoded by the exons 1-7 followed by aminoglycoside 3'-phosphotransferase 
and β-galactosidase (Fig. 1A).  The Btk exon in the trap construct contained termination codons in all 
reading frames to prevent translation of the downstream Hgsnat exons (Fig. 1A). 
Mice homozygous for Hgsnat-Geo allele (Hgsnat-Geo mice) were viable and born in the 
frequency expected from Mendelian inheritance (26 of the first 100) indicating that disruption of the 
Hgsnat gene did not cause embryonic lethality. Mice showed normal growth, were fertile and 
behaviorally indistinguishable from wild type or heterozygous animals until the age of 11 months.   
Both expression of Hgsnat mRNA measured by RT-q-PCR (Fig. 1B) and the level of 
HGSNAT activity measured with fluorogenic substrate Muf-β-D-glucosaminide (Fig. 1C) in tissues 
and primary cultures of skin fibroblasts from the homozygous animals were reduced to 0.6-1.5% of 
that in wild type mice (below or close to detection limit of the method) confirming efficiency of the 
splicing outcome and validating the model biochemically. In the heterozygous mouse tissues 
HGSNAT activity was reduced to ~50% of wild type (Fig. 1C).  In contrast, β-galactosidase activity 
measured in liver, kidney, brain, muscle and lung tissues of the Hgsnat-Geo mice at pH 7.5 was 
  
significantly increased as compared to wild type mice (not shown) indicating that the Hgsnat-Geo 
fusion protein is produced but does not have N-acetyltransferase activity, which was expected because 
it is missing ~60% of the Hgsnat sequence including its predicted active site residue, His269 and 9 of 
11 transmembrane domains presumably forming the AcCoA-transporting channel(Durand et al., 
2010)  
Activities of other lysosomal glycosidases measured in the tissues of homozygous Hgsnat-Geo 
mice were either similar or higher than those in wild type mice and progressively increased with age 
of the animals suggesting augmented production of lysosomes previously described for the mouse 
models of other subtypes of MPS III and linked to lysosomal storage phenotype(Bhaumik et al., 1999; 
Li et al., 1999). In the Hgsnat-Geo mice the highest increase was observed in liver tissues where α-
galactosidase activity was induced ~5 fold and β-hexosaminidase activity, ~20 fold by the age of 6 
months (Fig. 1D).  β-Hexosaminidase activity was also increased 2-3 fold in the brain, lungs and 
kidney suggesting that lysosomal storage occurs also in these tissues.   
2. Hgsnat-Geo mice show reduced longevity, progressive behavioral changes and 
learning impairment. 
No visible signs of illness were observed in the homozygous Hgsnat-Geo mice until the age of 
11-12 months, when they showed weight loss, and abnormal gait. About 30% of animals at this age 
showed spasticity of hind limbs and loss of coordination in a balance test (supplemental video 1). At 
~65 weeks of age mice presented signs of urinary retention resulting in abdominal distension absent 
in human patients but present in mouse models of both MPS IIIA and MPS IIIB (Li et al., 1999) 
(Bhaumik et al., 1999) and had to be euthanized (Fig. 2A).  At all ages, heterozygous mice were 
clinically undistinguishable from their wild type siblings. No signs of skeletal abnormalities such as 
scoliosis reported previously in human patients or shortened scull with a “blunt” snout described in 
several MPS mouse models including those of MPS IIIA(Bhaumik et al., 1999) were detected in the 
  
homozygous Hgsnat-Geo mice by x-ray analysis (Fig. S1).  Similarly, we did not detect any signs of 
femoral head necrosis also reported for human MPS III patients (de Ruijter et al., 2013).    
 Neurological assessment (gait, posture, avoidance response, righting reflex, horizontal bar 
test, inverted wire screen test, all conducted on the group of 10 Hgsnat-Geo and 10 wild type by the 
same examiner blinded for the mouse genotype) was performed at 2 months, when MPS IIIA and B 
mice still show normal behavior and then repeated every 2 months with a naïve group of animals. Also 
every 2 months starting from the age of 4 months we studied motor activity using motor coordination 
test performed on an accelerating Rotarod treadmill for mice.  Neither neurological assessment nor the 
accelerating Rotarod test (Fig. S2) revealed any signs of neuromuscular pathology in Hgsnat-deficient 
mice up to the age of 10 months.  
In contrast, open field test performed 1 hour into their light cycle showed definite signs of 
increased activity and reduced anxiety including higher than average speed and distance travelled, 
increased frequency of crossing the central field and central distance traveled, as well as decreased 
frequency and duration of periods of immobility (Fig. 2B and supplemental video 2). The same trend 
was observed for both male and female mice but for female mice the differences with the control group 
became significant already at the age of 6 months whereas for male mice for most studied parameters 
the significant difference was observed only at 8 months. By the age of 10 months the signs of 
hyperactive behavior diminished resembling the trend observed in human MPS III patients (Fig. 2B).  
Hippocampal function was assessed at 5, 7, 8 and 10 months using the Morris Water Maze test 
to measure memory and spatial learning capability. To make sure that Hgsnat-deficient mice had no 
visual or motor deficits that could affect the outcome of the test we accessed their ability to reach a 
visible platform in a 3 days pre-training test. We found that there were no differences between the 
mutant and wild type groups as Hgsnat-deficient and wild type mice of all age groups showed similar 
escape latencies in the visible platform testing (Fig. 2C). Learning progress of mutant mice at ages of 
  
5, 7 and 8 months was similar to that of their wild type counterparts, as shown at the Fig. 2C for the 
8-month-old group.  In contrast, at the age of 10 months, Hgsnat-deficient mice needed significantly 
more time to find the hidden platform compared to their wild type counterparts, and to both wild type 
and mutant 8-month-old mice, suggesting impaired spatial learning. Additionally, in the probe trial on 
day 9 when the platform was removed, Hgsnat-deficient mice spent significantly less time and traveled 
less distance than wild type mice in the target quadrant where the platform used to be located, which 
indicated a decline of spatial memory (Fig. 2C). Moreover, 10-month-old mutant mice displayed lack 
of precision with less platform crossings compared to wild type counterparts, and to younger wild type 
and Hgsnat-deficient mice (Fig. 2C). 
3. Pathological changes in tissues 
Pathological examination of homozygous Hgsnat-Geo mice performed at the ages of 2, 4, 6, 
10 and 11-12 months did not reveal any gross changes in the visceral organs and brains, except for the 
strikingly reduced abdominal fat detected at 11-12 months. The same animals usually also had largely 
distended bladder filled with 1–2 ml of urine consistent with urinary retention (Fig. S3).  Microscopic 
examination however revealed multiple pathological changes in numerous tissues and organs already 
detectable at 2 months and progressively increasing with age.  
Hepatocytes in the centrolobular and intermediate zones showed microvacuolization of 
cytoplasm, which became more prominent with age (Fig. S4A). Immunostaining with antibody against 
cathepsin D (CathD) detected expanded lysosomal system in hepatocytes compatible with lysosomal 
storage starting from 2 months (Fig. S4B). Kupffer cells are increased in number starting from 2 
months and become enlarged and strongly stained for CathD at later stages, showing signs of 
transformation into foam cells (Fig. S4A-C). Besides Kupffer cells, liver sinusoids contained a sparse 
mixed inflammatory infiltrate. High-resolution analysis of liver tissues by electron microscopy 
revealed massive accumulation of vacuoles, either electron-lucent or containing a fine sparse material 
  
characteristic of glycosaminoglycan (GAG) storage in the cytoplasm of hepatocytes and less 
prominent storage of this type in Kupffer and Ito cells (Fig. S4E-H).  
In the spleen, storage dominated in splenic sinus endothelial cells (SSE) giving them an 
appearance resembling that of foam cells (Fig. S5). Population of macrophages in red pulp represented 
a mixture of small dendritic macrophages and slightly enlarged round cells containing autofluorescent 
lipopigment and corresponding to phagocytic phenotype. Macrophages in white pulp revealed mostly 
an inconspicuous stellate appearance. In general, there was no convincing presence in spleen tissue of 
macrophages with storage material even at the most advanced stages of disease (surviving 16-month-
old mice). CathD immunostaining was compatible with lysosomal storage in SSE and was increased 
starting from 2 months (Fig. S5A). Electron-lucent storage vacuoles in SSE were also detected by 
electron microscopy (Fig. S5I).  
Quantification of NeuN-stained neurons in the two selected areas of somatosensory cortex 
showed that neuronal loss in homozygous Hgsnat-Geo mice actually occurs starting from the age of 6 
months and continues throughout the life resulting by the age of 12 months in the >30% reduction of 
neuronal density in these areas  (Fig. 3A).  In the cerebellar cortex, Purkinje cell loss was massive in 
the anterior lobe with lobules I, II and III most severely affected and lobules IX and X less affected at 
12 months of age (Fig. S6). The number of GFAP-positive astrocytes and CD68-positive microglia 
cells became augmented starting from 4 months in all studied brain areas of the Hgsnat-Geo mice as 
compared with wild type mice and was further increased with age (shown for somatosensory cortex 
in Fig. 3B).  
The most striking phenomenon observed in all parts of brain was a coarse vacuolization of the 
cytoplasm of multiple CD68-positive cells giving them foam cell-like appearance (Fig. 3C). These 
cells dispersed in gray and less so in white matter were frequently found adjacent to neurons suggesting 
that they represent perineuronal microglia. Individual macrophage-like CD68-positive cells with 
  
cytoplasmic vacuoles were also detected in perivascular areas. Microglia cells containing storage 
materials were most prominent in caudatoputamen and in brain cortex. They were first detected in 2-
month-old mice, thus preceding pathologic changes in neurons and become more frequent at later 
stages. Contrary to microglial cells, neurons were mostly featured by finely granular appearance of 
their perikarya without marked distension. The granular material accumulated in these neurons with a 
variable intensity was strongly PAS-positive (Fig. 3D) and displayed intense autofluorescence (Fig. 
3E). Immunostaining with antibodies against CathD (Fig. 3F), revealed increased number and size of 
lysosomes in neurons of mutant mice. Neurons strongly stained with CathA were found in brain cortex, 
thalamus, hypothalamus, amygdala, midbrain, pons and cerebellum (Fig. S7). Accumulation of PAS-
positive and autofluorescent materials was most prominent in neurons present in deep cortical layers, 
in hippocampus and in cerebellum. Neurons in caudatoputamen showed little involvement. Incipient 
neuronal storage was detectable in 5-month-old mice and widespread yet irregular neuronal storage 
was present in 12-month-old animals.  No signs of lysosomal storage were detected in vascular 
endothelial cells (data not shown). 
EM performed in brain cortex confirmed that neurons and microglial cells had two distinct 
types of storage (Fig. 4). Cortical microglia displayed prominent accumulation of electron-lucent 
storage vacuoles or those with a sparse fine content.  In contrast, neuronal pathology was dominated 
by progressive lysosomal storage of electron-dense heterogeneous ceroid-like material and early 
detectable mitochondrial structural abnormalities. Mitochondria were pleomorphic and increased in 
number with many of them swollen with disorganized or reduced inner membranes. Storage in 
microglia was not accompanied by any structural mitochondrial changes. Storage compartments in 
neurons contained heterogeneous, granular and/or lamellar material, occasionally with lipid droplets. 
At the same time, EM of neurons did not reveal lysosomes containing classical zebra-bodies, but some 
storage deposits contained structures resembling degenerated mitochondria. At the most advanced 
  
stages of the disease (14-16 months), ultrastructural pattern in neuronal lysosomes was dominated by 
massive accumulation of closely packed fibrillary deposits often resembling storage material of a 
rectilinear and/or fingerprint type in neuronal ceroid lipofuscinoses (Fig. 4). 
Other studied mouse organs and tissues stayed generally unaffected even at 12 months of age 
except for urinary bladders, which were markedly distended with thin walls. A sparse presence of cells 
strongly stained for CathD and presumably having lysosomal storage was detected in lamina, 
muscularis propria and adventitia. Normally arranged cardiomyocytes without regressive changes 
were observed in heart. There was no fibrosis in the interstitium and interstitial elements did not show 
signs of lysosomal storage at the optical level. Similarly, lysosomal storage was not detectable in 
alveolar septa in lungs. Population of septal and alveolar macrophages was rich, with focally increased 
phagocytic activity and undistinguishable from that seen in wild type. Respiratory bronchial 
epithelium displayed increased staining for CathD suggestive of lysosomal storage. In kidney, 
increased immunostaining for CathD was detected in glomeruli and in epithelial cells of distal tubules 
and collecting ducts (Fig. S5E). Storage of electron-lucent vacuoles in fibroblasts, vascular pericytes 
and rarely in vascular endothelial cells was detectable at the ultrastructural level (Fig. S5J-L).  
4. Hgsnat-Geo mice show lysosomal GAG storage in neurons and microglial cells 
and ganglioside storage in non-lysosomal compartments of neurons 
To investigate if Hgsnat deficiency in mouse tissues resulted in impairment of heparan sulfate 
catabolism, total GAG in mouse brain and liver tissues were measured at the age of 2, 4, 6, 8, 10 and 
12 months (Fig. 5A).  In both tissues GAG levels were slightly increasing with age while remaining 
significantly higher than in the wild type mice (on average two fold increase in brain and almost ten 
fold increase in liver at 12 months).  At the same time, total GAG in brain tissues of Hgsnat-Geo mice 
at all ages was significantly lower than in MPS IIIB mice.   
  
GAG accumulation at the cellular level was studied by immunohistochemistry using 
monoclonal 10E4 antibody specific against a native HS epitope (David et al., 1992), which detected 
increased staining of cytoplasmic LAMP-1-positive organelles in multiple cells throughout 
somatosensory cortex and all regions of hippocampus. The lysosomal HS storage was detected in 
multiple NeuN-positive neurons, but even more intense 10E4 staining was detected in the cells 
negative for NeuN, but positive for the markers of activated microglia cells: Alexa 568-labeled 
isolectin B4 (ILB4), and CD68 (Fig. 5B).   
Tandem mass spectrometry demonstrated ~2 fold increased levels of GM2 and GM3 gangliosides 
in the brain tissues of 4-month-old Hgsnat-Geo mice as compared to their wild type siblings (Fig. 5C), 
consistent with previously reported storage of these lipids in the mouse models of MPS IIIA and 
B(Bhaumik et al., 1999; Li et al., 1999). Accumulation of gangliosides in brain tissues was further 
studied by immunohistochemistry using the human-mouse chimeric monoclonal antibody, 
KM966(Nakamura et al., 1994) specific to GM2 ganglioside(Huang et al., 1997) and mouse 
monoclonal antibody specific to GM3 ganglioside.  Both gangliosides, almost undetectable in the brain 
of wild type mice (Fig. S8) were highly present in the brains of Hgsnat-Geo mice (Fig. 5D). The 
ganglioside storage was observed in most areas of the brain, including the cerebellum, but was more 
prominent in deep layers of cortex and hippocampus (Fig 5D and Fig. S8).  
 All ganglioside-accumulating cells were recognized by the anti-NeuN antibody and were not 
stained with ILB4 indicating that they are neurons but not microglial cells (Fig. 5D). In contrast to 
GAG accumulation both the number of ganglioside-positive granules in the neurons and their size 
were dramatically increasing between the ages of 8 and 12 months (Fig. S8). Intriguingly, when the 
tissue sections were co-stained for both GM3 and GM2 gangliosides, we detected only modest level of 
co-localization indicating that the corresponding storage granules tend to segregate from each other 
(Fig. 5D).  Similar pattern was previously observed in MPS IIIA and B mouse models (McGlynn et 
  
al., 2004). Also, we observed only partial co-localization between the stored gangliosides and 
lysosomal marker LAMP-1 (Fig. 5D), which could indicate that the gangliosides are accumulated in 
the compartments having both lysosomal and non-lysosomal origin.  
When we, however, co-stained the cells for gangliosides and the mitochondrial marker 
cytochrome c oxidase subunit 4 (Cox4) we detected a high degree of co-localization (Fig. 5D) 
suggesting that some of the storage granules could appear in the result of impaired mitophagy also 
consistent with the results of the EM analysis of neurons (as described above). Cox4 staining also 
revealed that the mitochondrial network is less organized and the ratio between the fused and single 
mitochondria is reduced in the tissues of the mutant mice (Fig. S9).  
5. Brain tissues of Hgsnat-Geo mice show altered autophagy, impaired proteolysis 
and accumulation of missfolded proteins.  
Impaired autophagy associated with decreased lysosomal and proteosomal proteolysis was 
found to be a characteristic feature of cells in many lysosomal disorders (Bifsha et al., 2007), 
(reviewed in(Settembre et al., 2013)).  To test whether it is also the case for liver and brain tissues of 
Hgsnat-deficient mice we have analyzed the relative abundance of the two forms of light chain three 
protein (LC3). During the formation of the autophagosome a cytosolic form of LC3 (LC3-I) is cleaved 
and conjugated with phosphatidylethanolamine to form the LC3-phosphatidylethanolamine conjugate 
(LC3-II) tightly associated with the autophagosomal membranes, so the amount of LC3-II or the 
presence of LC3-positive punctate in the cytoplasm reflects the existence of autophagosomes. In liver 
tissues of Hgsnat-Geo mice the increased levels of the LC3-II were detected at all ages indicating 
increased autophagosomal genesis or decreased macroautophagic flux (Fig. S10).  In the brain, the 
increase of LC3-II was also detected, but only at the age of 6 months and older (Fig. 6A).  
The results of Western blot were consistent with the results of immunohistochemistry that 
showed presence of LC3 in the cytoplasm of medial entorhinal cortex (MEnt) neurons at 10 months 
  
of age (Fig. 6B). We also detected drastically increased neuronal levels of SCMAS (subunit C of 
mitochondrial ATP synthase) aggregates and ubiquitin suggestive of mitophagy and a general 
impairment of proteolysis. We also detected increased levels of O-GlcNAc-modified proteins, an 
indication of the ER stress often associated with impaired cellular proteolysis(Chatham and Marchase, 
2010) (Fig. 6C) 
Recent studies have demonstrated that neurons in certain brain areas of MPS IIIB and MPS 
IIIA mice, primarily dentate gyrus and MEnt involved in learning and memory have increased levels 
of protein markers of Alzheimer disease and other tauopathies leading to dementia such as lysozyme, 
hyperphosphorylated tau (Ptau), Ptau kinase, Gsk3β, and beta amyloid(Ohmi et al., 2009; Ohmi et al., 
2011). All these markers are also increased in the brains of Hgsnat-deficient mice (Fig. S11) although 
their levels are somewhat lower than those in the MPS IIIA and MPS IIIB mice of similar age (Ohmi 
et al., 2011).  
6. Mitochondrial energy metabolism is compromised in brain tissues of Hgsnat-
Geo mice 
To verify whether mitochondrial energy metabolism is affected in the brain cells of Hgsnat-
Geo mice we have measured activities of several mitochondrial respiratory chain enzymes including 
NADH:CoQ reductase (NQR, complex I), succinate:CoQ reductase (SQR, complex II), cytochrome c 
oxidase (COX, complex IV), NADH:cytochrome c reductase (NCCR, complex I+III), 
succinate:cytochrome c reductase (SCCR, complex II+III) in the isolated brain mitochondria. We also 
measured activities of pyruvate dehydrogenase (PDH) complex and citrate synthase (CS).   
 Activities of complex IV (COX) and complex II (SQR) enzymes were significantly lower in 
Hgsnat-Geo mice than in the corresponding wild type controls at the ages of 8 and 12 months and 8 
months, respectively (Fig. 7A).  No significant differences in activities of enzymes of complex I, 
complex I+III, complex III, and complex II+III of respiratory chain as well as PDH and control 
  
mitochondrial enzyme citrate synthase (CS) were found between Hgsnat-Geo and wild type mice. 
However, when we analyzed the activities of individual enzymes as a function of mouse age, we found 
that the activities of complex II (SQR), complex II+III (SCCR) and citrate synthase in Hgsnat-Geo 
mice decreased significantly with age, whereas no dependence was detected for the wild type animals 
(Fig. 7B). 
 Consistent with the gradual reduction of the activities of respiratory chain enzymes was the 
observed decrease of the total content of coenzyme Q10 in the brain tissues of Hgsnat-Geo mice.  At 
the age of 4 months the levels of Q10 in the wild type and Hgsnat-deficient mice were the same, but 
while in the wild type mice of older age Q10 stayed at the same level; in the brains of Hgsnat-Geo 
mice it showed a negative correlation with age and at the age of 12 months became significantly lower 
than that in wild type mice (Fig. 7).   
7. Progressive neuroinflammation in Hgsnat-Geo mice 
Chronic progressive neuroinflammation is well documented in mouse models of lysosomal 
neurodegenerative diseases including those of MPS IIIA and B, which are characterized by activation 
of resident microglia and astrocytes, infiltration of leucocytes from the periphery and production of 
the inflammatory cytokines(Ausseil et al., 2008; Ohmi et al., 2003; Wilkinson et al., 2012).  Two fold 
increased expression of inflammation markers, MIP1α (CCL3) and TNFα, in the brains of 
homozygous Hgsnat-Geo mice was detected as early as at 10 days after birth. The levels of these 
cytokines further increased with age reaching the maximum at 8 months of age (Fig. 8A). At the same 
time, IL-1-β and TGF-β were not significantly increased as compared with wild type controls.  
Similarly increased expression of MIP1α and TNFα cytokines was detected also in the brain tissues 
of MPS IIIA mice, whereas MPS IIIB mice had ~2 fold higher levels at all ages.  
Consistent with high expression level of cytokines brain tissues of Hgsnat-deficient mice 
showed increased levels of activated microglia cells detected by isolectin B4 staining (Fig. 8B) or 
  
antibodies against CD68 (Fig. 3B), whereas almost no staining was detected in matching controls.  
Besides, significantly higher amount of astrocytes stained with anti-GFAP antibodies was detected in 
the hippocampal area of mutant mice starting from the age of 4 months (Fig. 3B).  
Signs consistent with an immune reaction were detected also in the liver. Early activation of 
Kupffer cells preceding the substantial storage and increased presence in liver sinusoids of 
inflammatory cells was detectable in Hgsnat-Geo mice but not in wild type mice (Fig. S4).   
Discussion 
Altogether our data demonstrate that HGSNAT deficiency in mice results in lysosomal 
accumulation of HS, in multiple cell types, including brain neurons and microglia. In brain neurons 
HS accumulation is accompanied by secondary accumulation of gangliosides and increased lysozyme, 
pTau, Gsk3β, and beta amyloid levels.  Signs of general inflammation in the brain including activation 
of astrocytes, microglia and cytokine production, previously reported for other MPS mouse models 
are clearly present from the very early age. At the same time a lower level of GAG storage as compared 
to the MPS IIIB mouse model results in a reduced level of brain inflammation, later onset and slower 
progression of the disease.  
The main organs affected at the optical and ultrastructural levels are the brain, liver and spleen. 
Lysosomal storage consistent with accumulation of undegraded GAG developed early in hepatocytes, 
splenic sinus endothelium, and cerebral microglia, and to a lesser extent in liver Kupffer and Ito cells, 
in fibroblasts and in perivascular cells. In peripheral tissues, storage in epithelial and mesenchymal 
cells, except for hepatocytes occurred later and with a lesser intensity as compared to mouse MPS IIIA 
and MPS IIIB models(Bhaumik et al., 1999; Li et al., 1999). Presence of macrophages with storage 
materials in visceral organs was limited, except for liver Kupffer cells, which were activated and 
developed storage phenotype with age. 
  
In the brain, substantial HS storage in microglia was found as early as at 2 months and seems 
to be the initial pathological event more evident at the age of 2-4 months then pathological changes in 
neurons, and possibly explained by high phagocytic activity of microglia causing an extracellular 
substrate burden.  The storage was further increased with age in all examined brain regions. Foam 
microglial cells were frequently in a close contact to neurons. Storage vacuoles in microglia had a 
uniform electron-lucent appearance different from ceroid-type accumulation in neurons.  The 
apparently different storage patterns detected in microglia and neurons by EM could be also attributed 
to the loss of GAG during fixation of the cells, however further immunohistochemical analysis 
confirmed that lysosomal storage of HS in microglia exceeded that in neurons, whereas gangliosides 
accumulated mainly in neurons. 
Neuronal pathology was also featured by cytoplasmic accumulation of densely packed material 
in neuronal perikarya, which was likely a source of strong autofluorescence and positive 
immunostaining for SCMAS. Storage of granular autofluorescent material restricted to individual 
neurons at 5 months was detected throughout the whole neuronal population at 12 months, but even 
at this advanced stage, neurons showed variations in the amount of stored materials between brain 
regions and between cells within a region. Similar heterogeneous storage character was reported for 
the other MPS disease mouse models (McGlynn et al., 2004).  Neuronal loss was not a dominant 
feature at the early stage of the disease but it became significant at 10 months and further progressed 
with age. At the EM level, neuronal pathology was characterized by a combination of early detectable 
structural alterations in mitochondria, progressive lysosomal storage of heterogeneous material and 
massive lysosomal accumulation of deposits resembling those detected in neuronal ceroid 
lipofuscinoses. Similar “fingerprint-like” structures were previously detected in MPS IIIB mouse and 
identified as SCMAS aggregates (Ryazantsev et al., 2007). The mitochondrial network in neurons was 
disorganized and the partial impairment of OXPHOS enzymes (complex II, II+III and IV) in brain 
  
tissues was detected by enzymatic assays and immunohistochemical analysis, while mitochondrial 
compartment in age-matching controls did not reveal any abnormalities. 
Altogether our data characterize MPS IIIC as a neurodegenerative disorder with a dominant 
lysosomal and mitochondrial alterations in neurons. Furthermore, our findings suggest that autophagy, 
namely mitophagy represents a substantial source for accumulation of undegraded materials in the 
lysosomal system of neurons. 
The precise sequence of events that starts with the accumulation of HS and leads to a 
widespread brain pathology and neuronal death is yet to be determined, however our results allow 
hypothesizing that the malfunction and loss of neurons can be at least partially mediated by 
pathological changes in their mitochondrial system.  We speculate that the disease starts with 
accumulation of primary storage materials (mostly HS and HS-derived oligosaccharides) as 
documented by EM analysis and immunohistochemistry with HS-specific antibodies. These materials 
released presumably by exocytosis of lysosomes are known to induce general inflammation reactions 
in the brain by activating TLR receptors of microglia cells, resulting in release of multifunctional 
cytokines such as TNF-α and MIP-1-α, known to cause mitochondrial damage through formation of 
ROS and oxidative stress(Baregamian et al., 2009; Chen et al., 2010; Chuang et al., 2012; Vitner et 
al., 2012) eventually leading to neuronal death observed in somatosensory cortex and cerebellum 
(Purkinje cells).  In the cerebellar cortex, Purkinje cells degeneration typically observed in other LSDs 
(Macauley et al., 2008; Sarna et al., 2001) was also present. Although neurodegenerative disease can 
develop even without neuronal loss it is important to mention that neuronal death is observed in MPS 
III patients(Hamano et al., 2008).  Ganglioside accumulation detected in neurons starting from 2 
months is probably of non-lysosomal origin.  It could be caused by altered Golgi function as described 
previously for MPS IIIB mouse model(Roy et al., 2012). Stored lipids and gangliosides can also be 
partially of mitochondrial origin due to mitophagy and impaired catabolism of autophagosomal 
  
content.  Indeed, our data define accumulation of densely packed material displaying a strong 
autofluorescence as a determining feature in brain neurons of MPS IIIC mice at the advanced stage of 
the disease. Since these granules are SCMAS positive and their ultrastructural pattern strongly 
resembles that in neuronal ceroid lipofuscinoses we speculate that they are derived from 
autophagosomes. Impairment of autophagosome-lysosome fusion can also result in accumulation of 
deformed and misfunctional mitochondria otherwise eliminated through autophagy and lysosomal 
catabolism (de Pablo-Latorre et al., 2012; Osellame et al., 2013).  Out data suggest that autophagic 
alterations may be involved in the neuropathological changes in Hgsnat-Geo mouse nevertheless it 
remains to be determined whether autophagy is impaired or in contrast increased since the detected 
LC3-II accumulation can reflect both increased autophagy or defective proteolysis following 
formation of the autophagosome.  
Together, our data validate Hgsnat-Geo mouse as an animal model relatively well matching 
phenotype of human MPS IIIC. MPS IIIC stands out among lysosomal diseases since it is the only 
one caused by a deficiency of not a hydrolase but a transferase. It is also one of rare disorders involving 
defects of an integral membrane protein untreatable by enzyme replacement or hematopoietic stem 
cell therapy. This makes Hgsnat-Geo mouse a valuable model for experimental evaluation of the 
efficacy of novel therapeutic strategies that can be potentially applied for such disorders, including 
gene therapy, substrate deprivation therapy or novel methods of enzyme delivery. Besides, our model 
can provide important opportunity to better understand underlying pathogenic mechanisms of the 
disease, particularly regarding the central nervous system, given that human material is highly limited 
due to the relative rarity of MPS IIIC.  Finally, the mechanism of brain disease in MPS IIIC mouse 
model involving mitochondrial dysfunction and brain inflammation may represent a common 
phenomenon for metabolic neurodegenerative diseases.  It also justifies future studies to determine if 
  
the mitochondrial defects in MPS IIIC cells can be at least partially rescued by known anti-oxidative 
drugs.  
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Figure 1.  Targeting the Hgsnat gene in mice.   
  
(A) Strategy for producing the targeted disruption of the Hgsnat gene.  The gene trap vector used by 
TIGM contains a splice acceptor site (SA) upstream of a β-galactosidase⁄neomycin phosphotransferase 
(Geo) fusion gene followed by polyadenylation sequence (pA), PGK and BTK genes and splice donor 
site (SD) inserted into intron 7 of the Hgsnat gene as confirmed by genomic sequencing. Hence, the 
downstream exons 8–13 in the gene trap transcript were replaced by the Geo sequence. Exons in the 
mouse Hgsnat gene are shown as black numbered boxes and Geo-PGK-BTK cassette, as white boxes. 
Primers (E7-R, Geo-R, and E10-F) were used to measure the expression of the wild type Hgsnat and 
of the targeted Hgsnat-Geo alleles by RT-qPCR. 
(B) RT-qPCR shows that expression of the Hgsnat mRNA in brain and liver tissues of mice 
homozygous for the Hgsnat-Geo allele is reduced to 0.6 and 1.6% of that in the tissues of their wild 
type siblings.  Total RNA was extracted from tissues of 4-month-old wild type and Hgsnat-Geo mice 
and analyzed for Hgsnat expression by RT-qPCR.  The values were normalized for the level of control 
RPL32 mRNA. Data are expressed as means (±S.D.) of experiments performed with 6 mice for each 
genotype. 
(C) Deficient Hgsnat activity in tissues of mice homozygous for Hgsnat-Geo allele. Hgsnat activity 
was measured with fluorogenic substrate, Muf-β-D-glucosaminide in the tissues of 4-month-old wild 
type, Hgsnat-Geo+/- and Hgsnat-Geo mice or in cultured skin fibroblasts of wild type and Hgsnat-Geo 
mice.  Data are expressed as means (±S.D.) of independent experiments performed with tissues of six 
mice for each genotype or with three different cell cultures.   
(D) Lysosomal hydrolases are increased in tissues of Hgsnat-Geo mice.  Acidic α-galactosidase, 
β-galactosidase and total β-hexosaminidase activity were measured in the tissues of 1, 4 and 6 
month-old Hgsnat-Geo mice and their wild type siblings.  Data are expressed as means (±S.D.) of 




Figure 2.  Hgsnat-Geo mice have shorter life span and show signs of hyperactivity 
between the ages of 6 and 8 months and learning impairment at the age of 10 months.   
(A) Kaplan-Meier plot showing survival of Hgsnat-Geo mice (n = 50) and their wild type counterparts 
(n = 70).  By the age of 70 weeks the vast majority of Hgsnat-Geo mice died or had to be euthanized 
on the veterinarian request due to urinary retention.  
(B) Six and 8-month-old Hgsnat-Geo female mice show signs of hyperactivity and reduced anxiety 
compared to wild type mice as detected by open field test performed 1 h into their light cycle. Increased 
activity (total distance traveled) was detected starting from ~5 months of age, with significant 
hyperactivity at 8 months. Reduced anxiety (increased center activity) was detected starting from ~3 
  
months, with significant difference with wild type at 6 and 8 months. At 6 and 8 months Hgsnat-Geo 
mice also spent significantly less time immobile as compared to wild type mice. P value was calculated 
by two-way-ANOVA (* P < 0.05, ** P < 0.01). From 6 (2, 4 and 6 month old) to 10 (8 and 10 month 
old) naive mice were studied per age/per genotype. 
(C) Hgsnat-Geo mice showed impaired performance in the spatial memory-based Morris Water Maze 
test at 10 months. All mice showed similar average latencies on days 1-3 of visible platform testing. 
Whereas 8-month-old Hgsnat-Geo mice had latencies in the hidden platform testing similar to those 
of their wild type counterparts (days 4-8), 10-month-old mutant mice were significantly impaired in 
this spatial learning test. During the removed-platform probe trial on day 9, Hgsnat-Geo mice 
displayed reduced time in the target quadrant as compared to their wild type siblings. Numbers of 
passes over the previous location of the hidden platform were also reduced. Swim speed was 
comparable among all groups. Six mice were studied for each group. P value for escape latency was 
calculated by two-way-ANOVA (*** P < 0.001) and for the number of platform crossing and time in 
platform quadrant, by t-test (* P < 0.05, ** P < 0.01). 
  
 
Figure 3. Pathological changes in CNS of Hgsnat-Geo mice 
(A) Progressive loss of neurons in somatosensory cortex. NeuN-positive neurons were counted by two 
observers blinded for the mouse genotype in two similar fields on 3 sagittal sections (cut 1.44, 1.68 
and 1.92 mm from bregma) of S1 somatosensory cortex of each mouse; four (two male, two female) 
mice were studied for each age and each genotype. Two-way (age and genotype) ANOVA was used 
to test differences between the mouse groups: significant differences between the genotypes at a given 
age in Bonferroni post-test (* P < 0.05, ** P < 0.01) are shown.  
(B) Increased numbers of GFAP-positive astrocytes and C68-positive microglia are detected in the 
somatosensory cortex of Hgsnat-Geo mice. Somatosensory cortex (layer V) of 4-month and 10-month-
old Hgsnat-Geo mouse and wild type littermate control (WT); slides stained with chicken polyclonal 
antibodies against GFAP (AbCam ab4674, 1/600) and rat antibodies against mouse CD68 (MCA 1957, 
1/400), followed by Dylight TM 549-conjugated goat anti-chicken IgG (Jackson ImmunoResearch 
Laboratories 103-505-155, 1/50) and Alexa fluor 488-conjugated goat anti-rat IgG (Invitrogen, 1/400) 
  
antibodies. The nuclei were stained with DRAQ5 TM, (Thermo Scientific 62254, 1/ 1000). Bars 
represent 50 µm, bars in the inserts, 20 µm. 
(C) Presence in cortical gray matter of microglial cells with vacuolized cytoplasm and foam-like 
appearance. Microglial cells showing storage are either dispersed or adjacent to neurons (shown in 
details in the insert). Somatosensory cortex (layer V) of 12-month-old Hgsnat-Geo mouse and wild 
type littermate control (WT); H&E stain. Bars represent 100 µm, bars in the inserts, 30 µm. 
(D) Accumulation of PAS positive granular material is detectable in perikarya of multiple neurons in 
the brain of Hgsnat-Geo mouse. Microglia show presence of storage and foam-like appearance. Brain 
of wild type littermate control displays only discrete PAS positive deposits corresponding with age 
pigment. Inserts show detailed views of neurons and microglia. Somatosensory cortex (layer V) of 
12-month-old Hgsnat-Geo and wild type mice.  Bars represent 50 µm, bars in the inserts, 30 µm. 
 (E) A massive accumulation of granular autofluorescent ceroid is widely present in cortical neurons 
of 12-month-old Hgsnat-Geo mouse. Insert shows a detailed view of a neuron with ceroid deposits in 
the perikaryon. Brain of wild type littermate control contains a small amount of autofluorescent 
lipofuscin in individual neurons. Somatosensory cortex (layer V) of 12-month-old Hgsnat-Geo mouse. 
Bars represent 100 µm, bar in the insert, 30 µm. 
(F) Increased cathepsin D immunostaining comparable with lysosomal storage in microglia and 
neurons of 12-month-old Hgsnat-Geo mouse. Dispersed, perineuronal or perivascular microglia is 
strongly positive for Cathepsin D (marked by arrowheads). Lysosomal system in neurons is irregularly 
activated and shows a coarsely granular appearance. Neuronal perikarya are not markedly distended 
in contrast to microglia. Inserts show detailed views of both cell types. Somatosensory cortex (layer 
V) of 12-month-old Hgsnat-Geo and wild type mice. Bars represent 100 µm, bars in the inserts, 30 
µm. 
Panels show representative images of at least 30 studied for 4 Hgsnat-Geo and 4 wild type mice. 
  
 
Figure 4. Ultrastructural pathology in the brain of Hgsnat-Geo mice. 
  
 (A) Storage pattern in microglia detected at 5 months. Massive accumulation of vacuoles with single 
limiting membranes and a sparse fine content in the cytoplasm of a cortical microglial cell is 
compatible with lysosomal GAG storage. Lysosomes containing storage materials are marked by 
arrowheads. The microglial cell (nucleus is marked by an asterisk) is in a close proximity to a cortical 
brain neuron. Bar represents 2 µm.  
(B) Lysosomal system in a cortical neuron at 12 months is expanded and massively overloaded by 
electron dense material (marked by arrows). Bar represents 2 µm.  
(C) High magnification micrograph of a cortical neuron at 12 moths demonstrates a storage 
compartment (marked by arrows) containing ceroid-like granular and/or lamellar material packed with 
a variable density as well as occasional lipid droplets. Insert shows a detailed view of storage deposits. 
Bar represents 1 µm.  
(D) Storage of densely packed fibrillary material (marked by arrows) strongly resembling rectilinear 
or fingerprint-like ceroid deposits in neuronal lysosomes at advanced stages of the disease. Brain 
cortex of 16-month-old Hgsnat-Geo mouse. Bar represents 1 µm.  
Mitochondrial population in neurons of wild type mice at the age of 5 (E) and 12 months (G) is 
relatively uniform and is composed of normally shaped mitochondria (marked by arrows) with largely 
regular cristae (details are shown in the inserts). Bar represents 1 µm. 
Mitochondria in a neuron of Hgsnat-Geo mouse at the age of 5 months (F) are relatively numerous 
and pleiomorphic with some of them revealing incipient swelling (marked by arrowheads). Edematous 
mitochondria with largely dissolved cristae (marked by asterisks) but with remnants of double 
membranes (marked by double arrowheads) were detected occasionally. A detailed view of incipient 
mitochondrial abnormalities is shown in the insert. Bar represents 1 µm.     
At the age of 12 months (H), mitochondria in neurons of Hgsnat-Geo mice are clearly pleiomorphic 
with many of them displaying swelling and disorganization of their inner membranes (marked by 
  
arrowheads). Substantially edematous mitochondria with largely dissolved cristae are marked by 
asterisks. Insert shows a detailed view of highly edematous mitochondria with remnants of double 
membranes (marked by double arrowheads). Bar represents 1µm. 
(I) A higher magnification demonstrates structural mitochondrial abnormalities in a neuron of Hgsnat-
Geo mouse at 12 months. Mitochondria are swollen with disorganized (arrowheads) or even dissolved 
(asterisks) cristae and occasionally contain circular formations (marked by double arrows). Bar 
represents 500 nm. 
(J) A detailed view of a mitochondrion with inner membranes forming circular structures. 
(K) A detailed view of a highly edematous mitochondrion with dissolved cristae but with detectable 
remnants of double membranes (marked by double arrowheads). 




Figure 5. Accumulation of primary and secondary storage materials in tissues of Hgsnat-
Geo mice 
  
A) Total GAG were measured in the whole brain tissues of Hgsnat-Geo mice, α-N-
acetylglucosaminidase-deficient  (MPS IIIB) mice and their corresponding wild type controls as well 
as in liver tissues of Hgsnat-Geo and wild type mice. The data show means (±S.D.) of individual 
measurements performed with 15 mice for each age and genotype.   
B) Intralysosomal accumulation of heparan sulfate in the brain cells of Hgsnat-Geo mice.  Forty μm-
thick sagittal brain sections of 4-month-old wild type and Hgsnat-Geo mice were stained with anti-
HS and anti-LAMP-1 antibodies and either antibody against neuronal marker NeuN or microglial 
marker, isolectin B4 (ILB4) or with antibodies against HS, NeuN and CD68. Somatosensory cortex 
of wild type mouse does not show HS (green) staining while that of Hgsnat-Geo mouse contains 
multiple neurons (arrowheads) or microglia (asterisks) with lysosomal accumulation of HS.  Foamy 
microglia (negative for neuronal marker, NeuN, but positive for ILB4 or CD68) show on average an 
increased staining for HS compared to neurons.  
C) Levels of GM3 and GM2 gangliosides are increased in the total brain extracts of 4-month-old Hgsnat-
Geo mice as compared to their wild type siblings. Total lipids from brain tissue homogenates were 
extracted with chloroform/methanol 1:1 mixture and analyzed by tandem mass spectroscopy.   
D) Accumulation of gangliosides in cortical neurons of Hgsnat-Geo mice. Forty μm-thick sagittal 
brain sections of 8-month-old wild type and Hgsnat-Geo mice were stained with anti-GM2 antibodies 
and either microglial marker, isolectin B4 or antibodies against neuronal marker NeuN, GM3 
ganglioside, LAMP-1 and mitochondrial marker, cytochrome c oxidase subunit 4 (Cox4).  Slides were 
studied on a Zeiss LSM510 inverted confocal microscope. 




Figure 6. Brain tissues of Hgsnat-Geo mice show altered autophagy and lysosomal 
proteolysis. 
A) Increased levels of LC3-II were detected in the brain tissues of Hgsnat-Geo (H-G) mice at the age 
of 6 and 10 months but not at the age of 4 months by the Western blot. Total mouse brains were 
  
homogenized in 250 mM sucrose buffer and after removal of nuclei proteins were solubilized with 1% 
Triton X-100. Protein extracts were analyzed by Western blotting using antibodies specific for mouse 
LC3 and β-tubulin as a loading control. Panel shows representative data of three independent 
experiments performed with three Hgsnat-Geo and three wild type mice for each age. Inset graph 
shows ratios (means and S.D.) of signal intensities for LC3-II and LC3-I estimated with ImageQuant 
software. * P < 0.05 in unpaired two-tailed t-test. 
B) LC3 staining was present in the cytoplasm of MEnt neurons of 10-month-old but not of 4-month-
old Hgsnat-Geo mice.  
C) Signs of impaired lysosomal proteolysis and ER stress in the neurons of Hgsnat-Geo mice.  
SCMAS-positive aggregates, O-GlcNAc-modified proteins and increased staining for ubiquitin were 
detected in MEnt neurons of 10-month-old Hgsnat-Geo mice. The scale bars are 100 µm. The scale 
bars in the inserts are 30 µm. 
 
  
   
Figure 7. Partial impairment of mitochondrial oxidative phosphorylation system in the 
brains of Hgsnat-Geo mice 
(A) Activity of succinate: CoQ reductase (SQR, complex II) and cytochrome c oxidase (COX, 
complex IV) in isolated brain mitochondria of Hgsnat-Geo mice are reduced as compared with age-
matching wild type controls. Total content of coenzyme Q10 in brain homogenate of Hgsnat-Geo mice 
is reduced as compared with wild type controls.  The data show means (±S.D.) of individual 
measurements. Three mice were analyzed for each age and each genotype. * P < 0.05 in unpaired two-
tailed t-test.  
 (B) Correlation between the age and activities of succinate: CoQ reductase (SQR), succinate: 
cytochrome c reductase (SCCR), citrate synthase (CS), and total coenzyme Q10 content in the brain 
tissues of Hgsnat-Geo and wild type mice was analyzed by the linear regression method. For all 
parameters in the tissues of Hgsnat-Geo but not of wild type mice the slopes of linear regression lines 




Figure 8. Brain inflammation in Hgsnat-Geo mice.  
A) Total brain tissues of Hgsnat-Geo mice show progressively increased expression of inflammation 
markers, MIP1α (CCL3) and TNFα similar to those in MPS IIIA, but lower than those in MPS IIIB 
mouse models. Total RNA was isolated from whole mouse brain, reverse-transcribed to cDNA and 
quantification of cytokines was performed by RT-qPCR.  The data show ratios of the cytokine levels 
in Hgsnat-Geo mice and those in wild type controls (both normalized for the content of RLP32 
mRNA).  Data show mean values (±SD). At least three mice were analyzed for each age, sex and 
genotype. Two-way ANOVA was used to test differences between the mouse groups: significant 
differences between the mean values in Bonferroni post-test (*P < 0.05, ** P < 0.001) are shown. 
  
B) Increased number of activated microglial cells in brain cortex of Hgsnat-Geo mice. 40 μm-thick 
sagittal brain sections of wild type and Hgsnat-Geo mice were stained with HPR-conjugated 
microglial marker isolectin B4/DAB and counter-stained with haematoxylin as described (Wilkinson 
et al., 2012). The total number of microglial cells was counted for three adjacent 0.25 mm2 sections 
of somatosensory cortex. Data show mean values (±SD). Two mice were analyzed for each age, sex 






Figure S1. No bone deformation was detected by X-ray analysis of Hgsnat-Geo mice. Image 
shows representative radiographs of 2-month-old male Hgsnat-Geo (A) and wild type (B) mice taken 
with Faxitron MX2 instrument.  Four mice were analyzed for each genotype.  
  
 
Figure S2. No significant difference was observed in accelerating Rotarod performance between 
8-month-old wild type and Hgsnat-Geo mice.  
 Mice were placed on a rubber-covered rod (3.5 cm in diameter) rotating at 4 rpm. Mice were left for 
3 min for adaptation and then the rotation speed was gradually increased from 4 to 40 rpm over the 
course of 5 min and the latency to fall (in seconds) recorded. The results are shown as means (±SD) 
of nine tests performed during 3 consecutive days (three tests per day). Four male and four female 
mice were studied for each sex and genotype. P value was calculated by t-test. 
  
 
Figure S3. Representative dissection of 12-month-old Hgsnat-Geo mouse showing signs of 
urinary retention and a loss of abdominal fat. Both features are not detectable in the age-matching wild 
type mouse.  
  
 
Figure S4.  Profound lysosomal storage in liver of Hgsnat-Geo mice was detected at the optical 
(A-D) and ultrastructural (E-H) levels.  
 (A) Survey of liver parenchyma of 12-month-old Hgsnat-Geo mice showing microvacuolization in 
hepatocytes mainly in the intermediate zone and increased cellularity in liver sinusoids. Insert shows 
a detailed view of microvacuolization in the cytoplasm of hepatocytes and a Kupffer cell showing 
transformation into a foam cell. H&E stain. Bar represents 200 µm, bar in the insert, 30 µm.  
(B) Immunostaining for CathD reveals expanded lysosomal system in hepatocytes and in Kupffer cells 
in the liver of 12-month-old Hgsnat-Geo mice, comparable with lysosomal storage. Insert shows a 
discrete signal for CathD in hepatocytes of wild type littermate control mouse. Bars represent 50 µm. 
(C, D) Storage within the population of Kupffer cells and their early activation were detected in 
Hgsnat-Geo mice by immunostaining with rat monoclonal antibody (clone BM8) against Mouse 
Macrophage IgG2a (LS-C139904, LifeSpan Bioscience). Positively stained Kupffer cells in liver 
sinusoids are enlarged and increased in number in 5-month-old Hgsnat-Geo mice (C) as compared to 
age matching wild type mice (D). Individual Kupffer cells display a storage phenotype with rounded 
  
vacuolated cytoplasm (C, insert). Kupffer cells in wild type mice are always slim, stellate or needle-
shaped (D, insert). Bars represent 200 µm, bars in inserts, 30 µm.  
 (E) Intensive lysosomal storage of soluble substances in the cytoplasm of a hepatocyte (HC) 
contrasting with rarely detectable storage vacuoles (marked by arrowheads) in a Kupffer cell (KC) in 
the sinusoid of 5-month-old Hgsnat-Geo mice.  
(F) Higher magnification of hepatocyte (HC) cytoplasm with accumulation of vacuoles surrounded by 
a single limiting membrane, either electronlucent or with a sparse fine content. Structures resembling 
autophagic vacuoles (marked by arrows) were occasionally detected.  
(G, H) Ultrastructural pattern characteristic for lysosomal storage of GAG (marked by arrowheads) 
was clearly detectable at 12 months in Kupffer cells (KC) (G) and in perisinusoidal Ito cells also 
containing droplets of neutral lipids in their cytoplasm (H). Bars represent 1 µm. 
Figure S5. Widespread lysosomal storage in epithelial and mesenchymal cells in Hgsnat-Geo 
mice. CathD immunostaining of lysosomal system (A-H) and electron microscopy of selected cell 
types (I-L). 
  
 Lysosomal system was expanded and activated in splenic sinus endothelium (A) and less so in 
bronchial respiratory epithelium (C), as well as in distal tubules, collecting ducts and glomeruli of 
renal cortex (E) of 12-month-old Hgsnat-Geo mice. Tissues of age-matching wild type animals (B, D 
and F) do not show these features. (G) A thin wall of distended urinary bladder of a 12-month-old 
Hgsnat-Geo mouse with a sparse presence in lamina and muscularis propria and adventitia of cells 
with expanded cytoplasm strongly positive for CathD. (H) Urinary bladder of age-matching wild type 
animal has normal wall thickness and structure. Inserts show detailed views of the cells. 
Electronlucent vacuoles surrounded by single membranes indicative of lysosomal storage of soluble 
material were detected in splenic sinus endothelium (I), skin vascular endothelial cells (J), 
perivascular pericytes (K) and fibroblasts (L) of 12-month-old Hgsnat-Geo mice. 
Bars in A, B and Insert C represent 30 µm, bars in C-F and Insert G, 100µm, bars in G and H, 200 
µm. Bars in I and L represent 1 µm, bars in J and K, 2 µm. 
 
  
Figure S6. Purkinje cell loss in the anterior cerebellar lobe of Hgsnat-Geo mouse at the age of 12 
months.   
(A-D) Calbindin immunostaining in the cerebellar cortex. Staining for Purkinje cells is almost absent 
in lobules I-III (A) when compared to remaining calbindin staining in lobules IX and X (B). Higher 
  
magnification of cerebellar cortex shows an exceptional presence of weakly positive Purkinje cells 
(marked by arrowheads) in the lobule III (C) and a substantially preserved Purkinje cell layer in the 
lobule X (D).  Bars in A and B represent 200 µm, bars in C and D, 100 µm. (E-F) Details of the 
Purkinje cells layer, H&E staining.  Purkinje cells are largely absent in the lobule III (E) in comparison 
to almost contiguous monolayer of Purkinje cells in the lobule X (F). Degenerating neurons with a 
shrunken condensed cytoplasm and nuclei are marked by arrowheads. Bars represent 50 µm.   
 
Figure S7. Increased CathD immunostaining in neurons compatible with lysosomal storage in 
Hgsnat-Geo mice as compared with relatively weak staining in wild type littermates was observed in 
in neocortex (A, B), hippocampus (C, D), amygdala (E, F), thalamus (G, H), hypothalamus (I, J), 
  
pons (K, L), cerebellar cortex (M, N) and cerebellar nuclei (O, P). Panels A-L show brains of 12-
month-old Hgsnat-Geo and wild type mice; panels M-P show brains of mice at the age of 5 months 
before extensive degeneration of Purkinje cells is detected. Bars represent 100 µm. 
 
Figure S8.  Progressive accumulation of GM2 ganglioside was detected in the hippocampus and 
cerebellum of Hgsnat-Geo mice.  Bars represent 20 µm (cerebellum) and 5 µm (hippocampus).  
 
  
Figure S9. Mitochondrial network show signs of disorganization in cortical neurons of HGSNAT-
Geo mice. Forty μm-thick sagittal brain sections of 8-month-old wild type and HGSNAT-Geo mice 
were stained with mitochondrial marker, cytochrome c oxidase subunit 4 (Cox4).  Slides were studied 
on a Zeiss LSM510 inverted confocal microscope. Arrows show collapsed mitochondria in neurons 
of Hgsnat-Geo mouse.  
  
Panels show representative images of at least 30 studied for 3 Hgsnat-Geo and 3 wild type mice for 
each age. Bars represent 10 µm. 
 
Figure S10. Increase of LC3-II in liver tissues of Hgsnat-Geo mice suggestive of impaired 
autophagy.  Livers of 4, 6 and 12-month-old Hgsnat‐Geo and wild type mice were homogenized in 
  
RIPA buffer. Protein extracts were analyzed by Western blot using antibodies specific for mouse LC3 
and β‐tubulin as a loading control.  
A. Panel shows representative data of 3 independent experiments.  
B. Graph shows ratios (means and S.D.) of signal intensities for LC3‐II and β‐tubulin estimated with 




Figure S11. Accumulation of brain protein markers of neurodegeneration associated with dementia: 
lysozyme, beta amyloid (A-beta), and Ptau kinase Gsk3β in MEnt and phosphorylated tau (PHF-tau 
Thr181) in dentate gyrus of 10-month-old Hgsnat-Geo mice. Bars represent 100 µm; bars in the 
inserts, 30 µm. 
Supplemental video 1. Video recording of 8-month-old male Hgsnat-Geo mouse showing loss 
of coordination.  
Supplemental video 2.  Video recordings of 8-month-old female wild type (a) and Hgsnat-Geo 
(b) mice in the open field test. Hgsnat-Geo mouse shows signs of hyperactivity and reduced anxiety 
compared to wild type mouse. 
 
